Skip to the content
Search
Clinical Advisory Network on Sex and Gender
#FirstDoNoHarm
Menu
Conference: Rethinking Youth Gender Medicine
Donate
Latest Posts
Meet CAN-SG
About us
Contact
FAQ
The Issues
Children and young people’s gender services
Summary of Cass Review
Unfinished business following NHS England ban on routine use of puberty blockers in children and adolescents
The spectre of suicide
A response to Dr Helen Webberley’s open letter to Dr Hilary Cass
Dr David Bell letter to Guardian about Gender Identity Development Service
Review of book by Hannah Barnes: ‘Time to Think: The Inside Story of the Collapse of the Tavistock’s Gender Service for Children’
Official statement in response to the closure of GIDS
Time for honest reflection, not defence
Puberty blockers
KCL response to FOI about scientific review of PATHWAYS trial
CAN-SG letter to PATHWAYS puberty blocker trial investigators, oversight board and regulators
Unfinished business following NHS England ban on routine use of puberty blockers in children and adolescents
Puberty blockers and teenage brain development
Summary of CAN-SG’s submission to NHS England’s consultation on Puberty Suppressing Hormones for Children and Adolescents with gender dysphoria or incongruence
Puberty Blocker Consultation Oct 23
Social transition
What is ‘Social Transition’ and why is it important?
Ethics
Ethical Concerns about Puberty Blocker Trials for Children
CAN-SG letter to PATHWAYS puberty blocker trial investigators, oversight board and regulators
Lessons from the wrong side of history
The spectre of suicide
What is the informed consent model in gender care?
CAN-SG write in support of the UKCP position statement
Gender dysphoria: Reconsidering ethical and iatrogenic factors in clinical practice.
Time for honest reflection, not defence
International perspectives
Letter to WHO expressing new concerns about influence of WPATH on transgender guideline development
Documentary raises serious concerns about Ireland’s youth gender care
The 2023 Dutch Debate Over Youth Transitions
Denmark Joins the List of Countries That Have Sharply Restricted Youth Gender Transitions
Gender dysphoria: Reconsidering ethical and iatrogenic factors in clinical practice.
Genspect Bigger Picture Conference
Sex and gender in language, medicine, science and healthcare
Open Letter to NHS chiefs: The importance of the word “woman” in communication about women’s health
When we are at our most vulnerable
Conversion therapy
Why legislation to ban so-called Conversion Therapy could harm people with gender-related distress
James Esses Reaches Settlement With UK Council For Psychotherapy
What is meant by the term ‘conversion therapy’?
Conversion practices bill: CAN-SG’s evidence
A psychiatrist’s views on risks of “conversion practices” ban
A child psychiatrist’s views on “conversion practices” ban
A GP’s views on risks to young women of a “conversion practices” ban
Banning “conversion practices” for gender identity could make it harder for GPs to have exploratory conversations with their patients
Dr Bob Withers, psychotherapist, on risks of “Conversion Practices” ban
Dr David Bell on the risks to children and young people of a “conversion practices” ban
Dr Az Hakeem on Conversion Practices ban
Conversion Practices Ban: CAN-SG’s evidence, May 2023
Webinars and Conferences
Are Academics Allowed To Talk About Sex?
Puberty Blocker Trial Ethics
Childhood Social Transition
Problems with Conversion Therapy Ban
Introducing the Clinical Advisory Network on Sex and Gender
Conference 2024
Watch our Conference
Conference report
Talks and Presentations CAN-SG Conference
Resources
Academic papers
On medical interventions for gender dysphoria
On psychological interventions for gender dysphoria
On detransition
On suicide
On sex and gender in medicine
Briefings
CAN-SG letter to PATHWAYS puberty blocker trial investigators, oversight board and regulators
CAN-SG Letter to Health Research Authority April 2025
Letter to PATHWAYS trial regulators December 2025
WPATH files
CAN-SG letter to PATHWAYS puberty blocker trial investigators, oversight board and regulators
CAN-SG statement on the proposed WHO guideline for the health of trans and gender diverse people
CAN-SG submission to NHS England Interim Clinical Policy: Puberty Suppressing Hormones for Children and Adolescents who have Gender Incongruence/Dysphoria
Conversion Practices Bill: CAN-SG’s evidence, May 2023
CAN-SG Response to Interim Service Specification Consultation November 2022
Parliamentary debate briefing 13th June 2022
Conversion Therapy Bill submission
Open Letter to Nursing & Midwifery Council: Nurses request bodies withdraw from Stonewall’s Diversity Scheme
Sign Our Declaration
Comments from signatories
Search
applause-mov
Post author
By
admin@cansg
Post date
24th March 2024
Clinical Advisory Network on Sex and GenderClinical Advisory Network on Sex and Gender